Local Laboratory Corp is a company.
Key people at Local Laboratory Corp.
Local Laboratory Corp was founded by April Underwood (Founder and CEO).
Local Laboratory Corp was founded by April Underwood (Founder and CEO).
Local Laboratory Corp appears to refer to Labcorp Holdings Inc., a leading global laboratory services company headquartered in Burlington, North Carolina. Labcorp provides extensive diagnostic testing and drug development services that support healthcare decisions worldwide.
---
Labcorp builds and operates one of the largest clinical laboratory networks globally, offering a broad range of diagnostic tests—from routine blood work to advanced genetic and molecular diagnostics. It serves healthcare providers, pharmaceutical and biotechnology companies, researchers, and patients. Labcorp’s services help diagnose diseases, guide treatment decisions, and accelerate drug development. The company processes over 160 million tests annually and supports about 84% of new FDA-approved drugs through its Biopharma Laboratory Services segment. Its growth is driven by continuous innovation in testing technologies and expansion into home-based testing and global markets[1][3][5].
---
Labcorp’s roots trace back to the early 1970s when Thomas Edward Powell III and his brothers founded Biomedical Laboratories in a hospital basement in Burlington, North Carolina. Over the decades, through strategic mergers and acquisitions—including the merger of National Health Laboratories (NHL) and Regional Biosciences Laboratories (RBL)—Labcorp evolved into a global life sciences leader. Key acquisitions such as the National Genetics Institute and ViroMed expanded its molecular and genetic testing capabilities. The company marked its 50th anniversary in 2019, having transformed from a local lab into a global enterprise deeply integrated into patient care and drug development. Labcorp was also a pioneer in COVID-19 testing, launching the first FDA emergency authorized PCR test and at-home kits[2][1].
---
---
Labcorp rides the wave of precision medicine, genomics, and digital health trends, leveraging big data and molecular diagnostics to personalize healthcare. The timing is critical as healthcare increasingly shifts toward data-driven, patient-centric models and remote testing solutions. Market forces such as rising chronic disease prevalence, demand for faster drug development, and the COVID-19 pandemic have accelerated the need for scalable, reliable laboratory services. Labcorp’s integration of diagnostics with biopharma research positions it as a key enabler in the evolving healthcare ecosystem, influencing clinical practice, pharmaceutical innovation, and public health monitoring[1][2][5].
---
Labcorp is poised to expand its leadership in precision diagnostics and drug development support, with growth fueled by advances in genomics, AI-driven data analytics, and expanded at-home testing capabilities. Emerging trends like personalized medicine, telehealth, and real-world evidence generation will shape its trajectory. As healthcare systems demand more integrated and rapid diagnostic solutions, Labcorp’s influence is likely to deepen, reinforcing its role as a critical bridge between laboratory science and patient care.
The company’s ongoing innovation and global footprint suggest it will remain a cornerstone of the life sciences and healthcare infrastructure, continuing to improve health outcomes worldwide by harnessing science for human good[5][6].
Key people at Local Laboratory Corp.
